In animal models of XLH and ARHR, the global genetic deletion of Fgf23 completely suppresses FGF23 production, which results in hyperphosphatemia, hypercalcemia, increased vitamin D levels, ectopic calcifications, and early mortality (23–25, 40). This evidence concerns the gene FGF23 and hyperphosphatemia.